Kala Pharmaceuticals has named Howard B. Rosen as chairman of its board of directors. Previously, he worked at Pearl Therapeutics where he served as interim president and CEO. Based in Waltham, Mass., Kala Pharmaceuticals is a developer of treatments for ocular diseases. Its backers include Lux Capital, Polaris Venture Partners, Third Rock Ventures and Crown Venture Fund.
4 min read · 06 January 2014
Motorola Solutions has bought Twisted Pair Solutions. No financial terms were disclosed. Headquartered in Seattle, Twisted Pair Solutions is a provider of communications solutions. Its backers included Chart Venture Partners, Core Capital Partners and Ignition Partners.
3 min read · 03 January 2014
According to VentureWire, StageOne Ventures is currently seeking to raise $100 million for its second fund. Based in Tel Aviv, Israel, StageOne Ventures invests in early-stage companies in the software, communications, internet and media sectors.
1 min read · 03 January 2014
ChromaDex Corp. has named Steve Allen to its board of directors. A former Nestle executive, Allen is currently the non-executive vice-chairman of the LA-based investment firm 6 Pacific Group. Based in Irvine, Calif., ChromaDex, which is backed by DSM Venturing, is a natural products company.
3 min read · 03 January 2014
MELA Sciences has named Jeffrey F. O’Donnell to its board. O'Donnell is a managing director at BioStar Ventures. Also, Rose Crane, CEO of MELA, has assumed CFO duties on an interim basis following the resignation of Richard I. Steinhart, who also served as senior vice president of finance. Based in Irvington, NY, MELA Sciences is a medical device company that assists dermatologists in melanoma evaluation and diagnosis.
4 min read · 03 January 2014
Tembo Gold Corp. is raising up to C$1.28 million in a private placement. Tembo is selling up to 12,800,000 units of its stock at a price of C$0.10 per unit. The investors are NAMF II (Mauritius) Limited, NAMF II South African Partnership and Concept Capital Management Limited. According to the company, the net proceeds will be used to fund ongoing exploration costs on its properties in Tanzania. Based in Toronto, Tembo Gold Corp. is a mineral exploration company focused on the exploration and development of gold projects in Tanzania and the rest of Africa.
3 min read · 03 January 2014
Fortune has reported that Revance Therapeutics has filed for an $86.25 million IPO. The company plans on listing the stock on the NASDAQ under the ticker symbol "RVNC." Cowen & Co. and Piper Jaffray will serve as lead underwriters. Based in Newark, California, Revance is a biopharmaceutical company that is providing solutions for the way drugs are delivered. Its backers include Essex Woodlands Health Ventures, NovaQuest Capita, Technology Partners, Vivo Ventures, Shepherd Ventures, Palo Alto Investors, Pac-Link Ventures and Essex Capital Corp.
1 min read · 02 January 2014
According to a news announcement on its site, Agilis Biotherapeutics has closed $8 million in funding. The investors were not named. The financing will be used to develop a treatment for Friedreich's ataxia in partnership with Intrexon Corp. Based in New York, Agilis is a biotech company focused on rare genetic diseases. To read further details about the funding, visit here.
1 min read · 02 January 2014
According to the Silicon Valley Business Journal, Nest Labs is raising between $150 million and $200 million in funding. The publication reported that this amount places the company's valuation at between $2 billion and $3 billion. The investors in this round have not been named. Based in Palo Alto, Calif., Next Labs, which was founded by former Apple executive Tony Fadell, is a maker of a smart-home thermostat.
1 min read · 02 January 2014
AirVend has secured $1.2 million in seed funding. The round was led by 365 Retail Markets with participation from PS27 Ventures. Based in Provo, Utah, AirVend is a touchscreen device that displays nutritional information and sends real-time data.
3 min read · 02 January 2014
